There are 1076 resources available
136P - Tislelizumab combined with donafenib and GEMOX as first-line treatment for advanced biliary tract cancer: A single-center, single-arm, phase II study
Presenter: Yiming Zhao
Session: Poster Display session
Resources:
Abstract
137P - A single-arm, multicenter, phase II study of hepatic arterial infusion chemotherapy (HAIC) combined with donafenib and sintilimab as first-line treatment for unresectable intrahepatic cholangiocarcinoma (CHANCE 2203)
Presenter: Gaojun Teng
Session: Poster Display session
Resources:
Abstract
139P - KEYNOTE-966: 3-year follow-up for pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) vs placebo (pbo) + gem/cis for patients (pts) with advanced biliary tract cancer (BTC)
Presenter: Makoto Ueno
Session: Poster Display session
Resources:
Abstract
140P - Tinengotinib (TT-00420) in combination with atezolizumab (atezo) in Chinese patients (pts) with biliary tract carcinoma (BTC): Efficacy and safety results from a phase Ib/II study
Presenter: Panpan Zhang
Session: Poster Display session
Resources:
Abstract
141P - Predictive MINT pathological risk score for adjuvant chemotherapy in resected cholangiocarcinoma: A propensity score matched multicenter study in Thailand
Presenter: Kaewta Jeerapradit
Session: Poster Display session
Resources:
Abstract
142P - Lenvatinib demonstrates enhanced efficacy in IDH1-mutated cholangiocarcinoma with hyper vascular features on abdominal CT
Presenter: Wen-Chi Wu
Session: Poster Display session
Resources:
Abstract
143P - Claudin-18.2 is a poor prognostic indicator for intrahepatic cholangiocarcinoma
Presenter: Yu Hsuan Kuo
Session: Poster Display session
Resources:
Abstract
144P - The role of adjuvant chemo(radio)therapy in the management of Esophageal keratinizing squamous cell carcinoma
Presenter: Mohamed Elkarany
Session: Poster Display session
Resources:
Abstract
145P - Efficacy and safety in the KEYNOTE-966 study of pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): Impact of hepatitis B virus (HBV) infection
Presenter: Thomas Yau
Session: Poster Display session
Resources:
Abstract
146P - A retrospective study of the efficacy of gemcitabine combined with capecitabine versus capecitabine alone for biliary tract cancer after curative resection
Presenter: Jiaman Ma
Session: Poster Display session
Resources:
Abstract